MarketThe peptide receptor radionuclide therapy (PRRT) market is projected to be valued at approximately USD 591.83 million ...

Detailed price information for JP Morgan Chase & Company (JPM-N) from The Globe and Mail including charting and trades.

Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Spinach, green tea, apples, celery, asparagus, coffee and berries are all good examples of foods high in polyphenols - which ...

Losing weight can bolster confidence, but it can also impact how others treat you. Knowing how to manage relationships and ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Axsome's financials show a market cap of $4.1bn and a cash runway of 4-5 quarters, but risks include potential dilution and FDA approval uncertainty. Learn more on AXSM stock here.